Carl L. Gordon, Director at BlossomHill Therapeutics, Inc. (BLSM), bought 625,000 shares at $16.00 ($10.0M) on 2026-08-10, disclosed to the SEC on 2026-08-12.
Director Carl L. Gordon purchased $10 million of BLSM stock at $16.00, marking the largest insider purchase in the company's history and signaling strong conviction in the stock's near-term trajectory.
The stock is currently trading at $16.28, representing a 3.67% discount from its 52-week high of $16.90 and a 6.75% premium to its 52-week low of $15.25.
The purchase occurred within a 5-insider buying cluster over the last 30 days, indicating a coordinated effort by the team to accumulate shares.
Insider buying momentum may be driven by a lack of upcoming catalysts, as the next earnings date is currently unreported.
Nothing distinguishes this filing.
| Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |
| MBX | BUY | 2024-09-17 | $12.0M | — | Filing → |